Sustained release drug delivery devices

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424422, 424423, 424424, 424427, 424468, 5147722, 514912, 514914, A61K 922, A61K 932

Patent

active

053784758

ABSTRACT:
A method and device for treating a mammalian organism to obtain a desired local or systemic physiological or pharmacological effect is provided. The method includes administering a sustained release drug delivery system to a mammalian organism in need of such treatment at an area wherein release of an effective agent is desired and allowing the effective agent to pass through the device in a controlled manner. The device includes an inner core or reservoir comprising the effective agent; a first coating layer, which is essentially impermeable to the passage of the effective agent; and a second coating layer, which is permeable to the passage of the effective agent. The first coating layer covers at least a portion of the inner core; however, at least a small portion of the inner core is not coated with the first coating layer. The second coating layer essentially completely covers the first coating layer and the uncoated portion of the inner core.

REFERENCES:
patent: 3416530 (1968-12-01), Ness
patent: 3618604 (1971-11-01), Ness
patent: 3630200 (1971-12-01), Higuchi
patent: 3632739 (1972-01-01), Kornblum
patent: 3896819 (1975-07-01), Zaffaroni et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 3961628 (1976-06-01), Arnold
patent: 3977404 (1976-08-01), Theeuwes
patent: 3980463 (1976-09-01), Muramoto et al.
patent: 3993071 (1976-11-01), Higuchi et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4014334 (1977-03-01), Theeuwes et al.
patent: 4014335 (1977-03-01), Arnold
patent: 4034758 (1977-07-01), Theeuwes
patent: 4036227 (1977-07-01), Zaffaroni et al.
patent: 4077407 (1978-03-01), Theeuwes et al.
patent: 4111201 (1978-09-01), Theeuwes
patent: 4111203 (1978-09-01), Theeuwes
patent: 4135514 (1979-01-01), Zaffaroni et al.
patent: 4142526 (1979-03-01), Zaffaroni et al.
patent: 4186184 (1980-01-01), Zaffaroni
patent: 4200098 (1980-04-01), Ayer et al.
patent: 4247498 (1981-07-01), Castro
patent: 4256108 (1981-03-01), Theeuwes
patent: 4290426 (1981-09-01), Luschen et al.
patent: 4326525 (1982-04-01), Swanson et al.
patent: 4327725 (1982-05-01), Cortese et al.
patent: 4439196 (1984-03-01), Higuchi
patent: 4475916 (1984-10-01), Himmelstein
patent: 4519801 (1985-05-01), Edgren
patent: 4519909 (1985-05-01), Castro
patent: 4522625 (1985-06-01), Edgren
patent: 4609374 (1986-09-01), Ayer
patent: 4615698 (1986-10-01), Guittard et al.
patent: 4624847 (1986-11-01), Ayer et al.
patent: 4627850 (1986-12-01), Deters et al.
patent: 4652441 (1987-03-01), Okada et al.
patent: 4657543 (1987-04-01), Langer et al.
patent: 4673405 (1987-06-01), Guittard et al.
patent: 4681755 (1987-07-01), Columbo et al.
patent: 4692336 (1987-09-01), Eckenhoff et al.
patent: 4693886 (1987-09-01), Ayer
patent: 4711782 (1987-12-01), Okada et al.
patent: 4716031 (1987-12-01), Eckenhoff et al.
patent: 4717567 (1988-01-01), Wu et al.
patent: 4720384 (1988-01-01), Di Luccio et al.
patent: 4730013 (1988-03-01), Bondi et al.
patent: 4777049 (1988-10-01), Magruder et al.
patent: 4786500 (1988-11-01), Wong
patent: 4832957 (1989-05-01), Dempski et al.
patent: 4839177 (1989-06-01), Columbo et al.
patent: 4861627 (1989-08-01), Mathiowitz et al.
patent: 4877618 (1989-10-01), Reed, Jr.
patent: 4889720 (1989-12-01), Konishi
patent: 4891223 (1990-01-01), Ambegaonkar et al.
patent: 4898733 (1990-02-01), DePrince et al.
patent: 4913906 (1990-04-01), Friedman et al.
patent: 4927687 (1990-05-01), Nuwayser
patent: 4952402 (1990-08-01), Sparks et al.
patent: 4994273 (1991-02-01), Zentner et al.
patent: 5028435 (1991-07-01), Katz et al.
patent: 5098443 (1992-03-01), Parel et al.
patent: 5141752 (1992-08-01), Ayer et al.
Pearson et al, Proceed. Intern. Symp. Control Rel. Bioch. Mater. 17(1990) Controlled Release Society, Jul. 22-25, pp. 470, 171.
Sustained Release Drug Delivery Systems in Extracapsular Cataract Surgery, ARVO Annual Meeting (Apr. 29-May 4, 1990), Solomon et al.
Polyvinyl Alcohol Membrane Permeability Characteristics of 5-Fluorouracil, Journal of Ocular Pharmacology, vol. 4, No. 2 (1988), Smith et al.
Intraocular Sustained Release of ANtiviral Agents of AIDS, proceedings of the 17th International Symposium on Controlled Release of Bioactive Materials (Jul. 22-25, 1990), Smith et al.
"A Membrane Based Sustained Release Ocular Delivery System for 5-Fluorouacil", Investigative Ophthalomology and Visual Science, vol. 30, No. 4 (May 1989), Smith et al.
"Polyvinyl Alcohol Membrane Permeability Characteristics of Gancyclovir", Investigative Ophthalomology and Visual Science, vol. 30, No. 4 (May 1989), Pearson et al.
"5-Fluorouracil Sustained Release Device Implantation: Toxicology and Histology in Rabbits", vol. 31, No. 4 (May 1990), Hollins et al.
"Intravitreal Sustained Release of Gancyclovir", Investigative Ophthalmology and Visual Science, vol. 31, No. 4 (May 1990), Goins et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Sustained release drug delivery devices does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release drug delivery devices, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release drug delivery devices will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2209935

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.